These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 7967055

  • 1. [Clinical trial of protocol-AL851 for children with high-risk acute lymphoblastic leukemia. Kyushu Yamaguchi Children's Cancer Study Group (KYCCSG)].
    Matsuzaki A, Ishii E, Ueda K, Yanai F, Nibu K, Take H, Koga H, Miyazaki S, Inoue T, Miyake K.
    Rinsho Ketsueki; 1994 Sep; 35(9):862-70. PubMed ID: 7967055
    [Abstract] [Full Text] [Related]

  • 2. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A, Ishii E, Okamura J, Eguchi H, Yoshida N, Yanai F, Inoue T, Miyake K, Ishihara T, Tsuboi C.
    Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
    [Abstract] [Full Text] [Related]

  • 3. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Ishii E, Eguchi H, Matsuzaki A, Koga H, Yanai F, Kuroda H, Kawakami K, Ayukawa H, Akiyoshi K, Kamizono J, Tamai Y, Kinukawa N, Okamura J.
    Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
    [Abstract] [Full Text] [Related]

  • 4. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G.
    Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
    [Abstract] [Full Text] [Related]

  • 5. Treatment of standard-risk acute lymphoblastic leukemia in children: the results of protocol AL841 from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A, Okamura J, Ishii E, Ikuno Y, Koga H, Eguchi H, Yanai F, Inada H, Nibu K, Hara T, Take H, Miyazaki S, Tasaka H.
    Pediatr Hematol Oncol; 1999 Sep; 16(3):187-99. PubMed ID: 10326217
    [Abstract] [Full Text] [Related]

  • 6. [Long-term follow-up of 2 therapeutic programs for the treatment of high-risk childhood acute lymphoblastic leukemia. Experience at the 20 de Noviembre National Medical Center].
    de Diego-Floreschapa J, López-Hernández M, Borbolla-Escoboza JR, Trueba-Christy E, Carrillo-Rosales T, González-Avante M.
    Gac Med Mex; 1999 Sep; 135(3):253-8. PubMed ID: 10425822
    [Abstract] [Full Text] [Related]

  • 7. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
    Kawai S, Fujimoto T, Zha Z, Asami K, Oka T, Kaneko Y, Takaue Y, Ninomiya T, Nishikawa K, Tsuchiya T.
    Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
    [Abstract] [Full Text] [Related]

  • 8. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E, PETHEMA Group.
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [Abstract] [Full Text] [Related]

  • 9. Improvement in treatment of childhood acute lymphoblastic leukemia: a 10-year study by the Children's Cancer and Leukemia Study Group.
    Koizumi S, Fujimoto T.
    Int J Hematol; 1994 Feb; 59(2):99-112. PubMed ID: 8018909
    [Abstract] [Full Text] [Related]

  • 10. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Lange BJ, Blatt J, Sather HN, Meadows AT.
    Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
    [Abstract] [Full Text] [Related]

  • 11. [Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
    Tsurusawa M, Katano N, Hirota T, Ito M, Yanase T, Asami K, Koizumi S, Nakayama M, Miyawaki T, Suzumiya J, Nishikawa K, Mugisima H, Horikoshi Y, Hatae Y, Iwai A, Anami K, Kikuchi M, Osima K, Kaneko Y, Kataoka S, Tanaka A, Chin M, Taga T, Watanabe A, Fujimoto T.
    Rinsho Ketsueki; 1998 Nov; 39(11):1092-8. PubMed ID: 9866420
    [Abstract] [Full Text] [Related]

  • 12. Acute lymphoblastic leukemia in young adults: two chemotherapeutic protocols for the treatment of 46 patients.
    Ho CL, Chen YC, Kao WY, Chao TY.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):45-52. PubMed ID: 10645050
    [Abstract] [Full Text] [Related]

  • 13. Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group.
    Feig SA, Ames MM, Sather HN, Steinherz L, Reid JM, Trigg M, Pendergrass TW, Warkentin P, Gerber M, Leonard M, Bleyer WA, Harris RE.
    Med Pediatr Oncol; 1996 Dec; 27(6):505-14. PubMed ID: 8888809
    [Abstract] [Full Text] [Related]

  • 14. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
    Sancho JM, Ribera JM, Oriol A, Hernandez-Rivas JM, Rivas C, Bethencourt C, Parody R, Deben G, Bello JL, Feliu E, Programa para el Estudio y Tratamiento de Hemopatias Malignas Group.
    Cancer; 2006 Jun 15; 106(12):2540-6. PubMed ID: 16700036
    [Abstract] [Full Text] [Related]

  • 15. Retrospective analysis of late intensification therapy with high-dose methotrexate for standard-risk acute lymphoblastic leukemia in childhood (CCLSG-S811 study). The Children's Cancer and Leukemia Study Group.
    Koizumi S, Fujimoto T, Sasaki K, Takeda T, Utsumi J, Mimaya J, Ohta S, Ninomiya T, Takaue Y.
    Int J Hematol; 1991 Aug 15; 54(4):307-13. PubMed ID: 1777605
    [Abstract] [Full Text] [Related]

  • 16. [Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
    Ribera JM, Grañena A, Rozman C, Urbano-Ispizua A, Bladé J, Carreras E, Cervantes F, Marín P, Sierra J, Nomdedeu B.
    Sangre (Barc); 1990 Feb 15; 35(1):26-32. PubMed ID: 2333581
    [Abstract] [Full Text] [Related]

  • 17. Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
    Desai SJ, Barr RD, Andrew M, deVeber LL, Pai MK.
    CMAJ; 1989 Oct 01; 141(7):693-7. PubMed ID: 2790605
    [Abstract] [Full Text] [Related]

  • 18. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
    Ortega JJ, Ribera JM, Oriol A, Bastida P, González ME, Calvo C, Egurbide I, Hernández Rivas JM, Rivas C, Alcalá A, Besalduch J, Maciá J, Gardella S, Carnero M, Lite JM, Casanova F, Martinez M, Fontanillas M, Feliu E, San Miguel JF, PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatías Malignas.
    Haematologica; 2001 Jun 01; 86(6):586-95. PubMed ID: 11418367
    [Abstract] [Full Text] [Related]

  • 19. [Extramedullary relapse in childhood acute lymphoblastic leukemia: experience at the Kyushu Yamaguchi Children's Cancer Study Group].
    Koga H, Miyazaki S, Ishihara T, Inoue T, Take H, Ishii E, Matsuzaki A, Ueda K, Yanai F, Nibu K.
    Rinsho Ketsueki; 1995 Feb 01; 36(2):76-83. PubMed ID: 7715089
    [Abstract] [Full Text] [Related]

  • 20. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J, Filippa DA, Qin J, Wollner N.
    Cancer; 2003 Sep 15; 98(6):1283-91. PubMed ID: 12973853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.